These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Effect of Gleason scores of lymph node metastases on prognosis of patients with prostate cancer. Ko K; Jeong IG; Choi WS; Lim JH; Suh JH; Ku JH; Park Y; Moon KC; Kim HH; Kim CS; Kwak C Int J Clin Exp Pathol; 2014; 7(9):6141-8. PubMed ID: 25337262 [TBL] [Abstract][Full Text] [Related]
65. Long-term results of treatment for prostate carcinoma by staging pelvic lymph node dissection and definitive irradiation using low-dose rate temporary iridium-192 interstitial implant and external beam radiotherapy. Puthawala AA; Syed AM; Austin PA; Cherlow JM; Perley JM; Shanberg AM; Sawyer DE; Ingram JE; Baghdassarian R; Wachs BH; Perley JE; Londrc A; Espinoza-Ferrel T Cancer; 2001 Oct; 92(8):2084-94. PubMed ID: 11596024 [TBL] [Abstract][Full Text] [Related]
66. High failure rate associated with long-term follow-up of neoadjuvant androgen deprivation followed by radical prostatectomy for stage C prostatic cancer. Cher ML; Shinohara K; Breslin S; Vapnek J; Carroll PR Br J Urol; 1995 Jun; 75(6):771-7. PubMed ID: 7542137 [TBL] [Abstract][Full Text] [Related]
67. Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer. Abdollah F; Sun M; Thuret R; Budäus L; Jeldres C; Graefen M; Briganti A; Perrotte P; Rigatti P; Montorsi F; Karakiewicz PI Eur Urol; 2010 Dec; 58(6):882-92. PubMed ID: 20932637 [TBL] [Abstract][Full Text] [Related]
68. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. Maffezzini M J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087 [No Abstract] [Full Text] [Related]
69. [Prognosis of the patients with prostate cancer clinically confined within the pelvis]. Akimoto S; Masai M; Isaka S; Shimazaki J; Murakami S; Igarashi T Hinyokika Kiyo; 1990 Sep; 36(9):1039-45. PubMed ID: 2239609 [TBL] [Abstract][Full Text] [Related]
70. Biochemical recurrence after robot-assisted extended pelvic lymphadenectomy for prostate cancer. Chenam A; Ruel N; Pal S; Barlog J; Lau C; Wilson T; Yuh B Can J Urol; 2018 Jun; 25(3):9340-9348. PubMed ID: 29900823 [TBL] [Abstract][Full Text] [Related]
71. Radical prostatectomy in high-risk prostate cancer: incidence of specimen-confined disease (pT2-pT3a N0R0) and outcomes. Mearini L; Nunzi E; Bini V; Lepri L; Bruno R; Porena M Urologia; 2014; 81(2):125-32. PubMed ID: 24474543 [TBL] [Abstract][Full Text] [Related]
72. No difference in biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients. Fergany A; Kupelian PA; Levin HS; Zippe CD; Reddy C; Klein EA Urology; 2000 Jul; 56(1):92-5. PubMed ID: 10869632 [TBL] [Abstract][Full Text] [Related]
73. Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy. Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE Eur Urol; 2008 Aug; 54(2):344-52. PubMed ID: 18511183 [TBL] [Abstract][Full Text] [Related]
74. Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy. Schiffmann J; Haese A; Leyh-Bannurah SR; Salomon G; Steuber T; Schlomm T; Boehm K; Beyer B; Larcher A; Michl U; Heinzer H; Huland H; Graefen M; Karakiewicz PI Eur J Surg Oncol; 2015 Nov; 41(11):1547-53. PubMed ID: 26117216 [TBL] [Abstract][Full Text] [Related]
75. Radical prostatectomy findings in patients with locally aggressive Grade group 5 prostatic adenocarcinoma and negative limited or extended pelvic lymph node dissection. Mallikarjunappa SS; Osunkoya AO Pathol Res Pract; 2023 Apr; 244():154415. PubMed ID: 36947981 [TBL] [Abstract][Full Text] [Related]
76. Lymph node yield during radical prostatectomy does not impact rate of biochemical recurrence in patients with seminal vesicle invasion and node-negative disease. Badani KK; Reddy BN; Moskowitz EJ; Paulucci DJ; Beksac AT; Martini A; Whalen MJ; Skarecky DW; Huynh LM; Ahlering TE Urol Oncol; 2018 Jun; 36(6):310.e1-310.e6. PubMed ID: 29625782 [TBL] [Abstract][Full Text] [Related]
77. The incidence of lymph node metastases in prostate carcinoma depends not only on tumor characteristics but also on surgical performance and extent of pelvic lymphadenectomy. Klevecka V; Musch M; Roggenbuck U; Stoerkel S; Kroepfl D Medicina (Kaunas); 2008; 44(8):601-8. PubMed ID: 18791337 [TBL] [Abstract][Full Text] [Related]
78. Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival. Bostwick DG; Qian J; Pacelli A; Zincke H; Blute M; Bergstralh EJ; Slezak JM; Cheng L J Urol; 2002 Sep; 168(3):1204-11. PubMed ID: 12187268 [TBL] [Abstract][Full Text] [Related]
79. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188 [TBL] [Abstract][Full Text] [Related]
80. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma. Elfving P; Lundgren R Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]